Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Fufang Biejia Ruangan Tablet vs original formulation in chronic hepatitis B–related liver fibrosis/cirrhosis
CTR20131869Phase 3Active
- Sponsor
- Inner Mongolia Furui Medical Science Co., Ltd.
- Start
- Feb 2014
- Countries
- 1
01
Overview
A Phase 3 trial of Fufang Biejia Ruangan in Chronic Hepatitis B (CHB), hepatic fibrosis, Cirrhosis, sponsored by Inner Mongolia Furui Medical Science Co., Ltd.. Started Feb 2014; status: active.
02
Drugs
Fufang Biejia Ruangan
03
Conditions
Chronic Hepatitis B (CHB)hepatic fibrosisCirrhosis
Beyond the preview
Go deeper on CTR20131869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131869.